Franklin Resources
KITE

Franklin Resources’s Kite Pharma, Inc. KITE Stock Holding History

Franklin Resources’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-244,444
Closed -$25.3M – 1543
2017
Q2 		$25.3M Hold
244,444
– – 0.01% 732
2017
Q1 		$19.2M Sell
244,444
-61,700
-20% -$3.82M 0.01% 796
2016
Q4 		$13.7M Sell
306,144
-102,700
-25% -$5.04M 0.01% 879
2016
Q3 		$22.8M Hold
408,844
– – 0.01% 772
2016
Q2 		$20.4M Buy
408,844
+6,400
+2% +$314K 0.01% 797
2016
Q1 		$18.5M Buy
402,444
+2,700
+0.7% +$131K 0.01% 828
2015
Q4 		$24.6M Sell
399,744
-7,800
-2% -$549K 0.01% 770
2015
Q3 		$22.7M Hold
407,544
– – 0.01% 809
2015
Q2 		$24.8M Hold
407,544
– – 0.01% 839
2015
Q1 		$23.5M Sell
407,544
-30,100
-7% -$2.02M 0.01% 856
2014
Q4 		$25.2M Buy
437,644
+81,700
+23% +$3.44M 0.01% 813
2014
Q3 		$10.1M Buy
+355,944
New +$8.81M ﹤0.01% 1038

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources's KITE Position: Q3 2017 in Review

Franklin Resources sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 244,444 shares — an estimated $25.3M sold.

Franklin Resources first reported a position in KITE in Q3 2014 and held it in 12 quarters. The position peaked at $25.3M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Franklin Resources reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Franklin Resources sold 244,444 Kite Pharma, Inc. shares in Q3 2017, an estimated $25.3M.
  • Franklin Resources first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 12 quarters.
  • Franklin Resources's Kite Pharma, Inc. position peaked at $25.3M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Franklin Resources's 13F filing for Q3 2017, filed 13 Nov 2017.